Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiki Murata

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Translational Lung Cancer Research|November 14, 2025
Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumabTakaaki Tokito, Koichi Azuma, Kenta Murotani, et al.
The Journal of Veterinary Medical Science|February 9, 2012
CT and MRI imaging diagnosis of epidural idiopathic sterile pyogranulomatous inflammation in a dog spinal canalDaiki Murata, Naoki Miura, Tomoko Iwanaga, et al.
Biofabrication|August 11, 2021
Bio-3D printing iPSC-derived human chondrocytes for articular cartilage regenerationAnna Nakamura, Daiki Murata, Ryota Fujimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2023
Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancerDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 20, 2022
[ROBOT-ASSISTED RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL -COMPARISON WITH LAPAROSCOPIC RADICAL CYSTECTOMY]Ryo Tasaka, Hideki Mochizuki, Hiroyuki Shikuma, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapyDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Plos One|December 18, 2018
Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printerKenichi Arai, Daiki Murata, Ana Raquel Verissimo, et al.
Plos One|November 25, 2020
Correction: Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printerKenichi Arai, Daiki Murata, Ana Raquel Verissimo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 20, 2021
Hematogenous metastasis to colon from gallbladder cancerDaiki Murata, Atsushi Yamaguchi, Yuzuru Tamaru, et al.
Thoracic Cancer|April 10, 2023
Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNorikazu Matsuo, Koichi Azuma, Kenta Murotani, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Translational Lung Cancer Research|November 14, 2025
Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumabTakaaki Tokito, Koichi Azuma, Kenta Murotani, et al.
The Journal of Veterinary Medical Science|February 9, 2012
CT and MRI imaging diagnosis of epidural idiopathic sterile pyogranulomatous inflammation in a dog spinal canalDaiki Murata, Naoki Miura, Tomoko Iwanaga, et al.
Biofabrication|August 11, 2021
Bio-3D printing iPSC-derived human chondrocytes for articular cartilage regenerationAnna Nakamura, Daiki Murata, Ryota Fujimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2023
Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancerDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 20, 2022
[ROBOT-ASSISTED RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL -COMPARISON WITH LAPAROSCOPIC RADICAL CYSTECTOMY]Ryo Tasaka, Hideki Mochizuki, Hiroyuki Shikuma, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapyDaiki Murata, Koichi Azuma, Kenta Murotani, et al.
Plos One|December 18, 2018
Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printerKenichi Arai, Daiki Murata, Ana Raquel Verissimo, et al.
Plos One|November 25, 2020
Correction: Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printerKenichi Arai, Daiki Murata, Ana Raquel Verissimo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 20, 2021
Hematogenous metastasis to colon from gallbladder cancerDaiki Murata, Atsushi Yamaguchi, Yuzuru Tamaru, et al.
Thoracic Cancer|April 10, 2023
Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNorikazu Matsuo, Koichi Azuma, Kenta Murotani, et al.
Pageof 8